Does Disruption of Optic Atrophy-1 (OPA1) Contribute to Cell Death in HL-1 Cardiomyocytes Subjected to Lethal Ischemia-Reperfusion Injury?

Cells. 2022 Sep 30;11(19):3083. doi: 10.3390/cells11193083.

Abstract

Disruption of mitochondrial structure/function is well-recognized to be a determinant of cell death in cardiomyocytes subjected to lethal episodes of ischemia-reperfusion (IR). However, the precise mitochondrial event(s) that precipitate lethal IR injury remain incompletely resolved. Using the in vitro HL-1 cardiomyocyte model, our aims were to establish whether: (1) proteolytic processing of optic atrophy protein-1 (OPA1), the inner mitochondrial membrane protein responsible for maintaining cristae junction integrity, plays a causal, mechanistic role in determining cardiomyocyte fate in cells subjected to lethal IR injury; and (2) preservation of OPA1 may contribute to the well-documented cardioprotection achieved with ischemic preconditioning (IPC) and remote ischemic conditioning. We report that HL-1 cells subjected to 2.5 h of simulated ischemia displayed increased activity of OMA1 (the metalloprotease responsible for proteolytic processing of OPA1) during the initial 45 min following reoxygenation. This was accompanied by processing of mitochondrial OPA1 (i.e., cleavage to yield short-OPA1 peptides) and release of short-OPA1 into the cytosol. However, siRNA-mediated knockdown of OPA1 content did not exacerbate lethal IR injury, and did not attenuate the cardioprotection seen with IPC and a remote preconditioning stimulus, achieved by transfer of 'reperfusate' medium (TRM-IPC) in this cell culture model. Taken together, our results do not support the concept that maintenance of OPA1 integrity plays a mechanistic role in determining cell fate in the HL-1 cardiomyocyte model of lethal IR injury, or that preservation of OPA1 underlies the cardioprotection seen with ischemic conditioning.

Keywords: OMA1 cristae remodeling; OPA1; apoptosis; cardiomyocyte; ischemia-reperfusion injury; ischemic preconditioning; mitochondrial morphosis; remote ischemic conditioning.

MeSH terms

  • Cell Death
  • GTP Phosphohydrolases / metabolism
  • Humans
  • Ischemia / metabolism
  • Metalloproteases / metabolism
  • Myocytes, Cardiac / metabolism
  • Optic Atrophy* / metabolism
  • RNA, Small Interfering / metabolism
  • Reperfusion Injury* / metabolism

Substances

  • RNA, Small Interfering
  • Metalloproteases
  • GTP Phosphohydrolases
  • OPA1 protein, human

Grants and funding

This research received no external funding.